Monogram Historical Income Statement
| MGRM Stock | 1.98 0.02 1.00% |
Historical analysis of Monogram Orthopaedics income statement accounts such as Selling And Marketing Expenses of 1.6 M can show how well Monogram Orthopaedics Common performed in making a profits. Evaluating Monogram Orthopaedics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Monogram Orthopaedics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Monogram Orthopaedics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Monogram Orthopaedics is a good buy for the upcoming year.
Monogram |
About Monogram Income Statement Analysis
Monogram Orthopaedics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Monogram Orthopaedics shareholders. The income statement also shows Monogram investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Monogram Orthopaedics Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Monogram Orthopaedics. It is also known as Monogram Orthopaedics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Monogram Orthopaedics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Monogram Orthopaedics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Monogram Orthopaedics' Net Interest Income is very stable compared to the past year. As of the 22nd of November 2024, Interest Income is likely to grow to about 258 K, while Selling And Marketing Expenses is likely to drop about 1.6 M.
| 2021 | 2023 | 2024 (projected) | Interest Expense | 21.7K | 19.5K | 18.5K | Depreciation And Amortization | 322.0K | 412.3K | 433.0K |
Monogram Orthopaedics income statement Correlations
Click cells to compare fundamentals
Monogram Orthopaedics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Monogram Orthopaedics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 31.8K | 95.7K | 322.0K | 386.7K | 412.3K | 433.0K | |
| Interest Expense | 62.2K | 124.5K | 54.3K | 21.7K | 19.5K | 18.5K | |
| Selling General Administrative | 1.2M | 956.6K | 1.9M | 2.9M | 4.1M | 4.3M | |
| Selling And Marketing Expenses | 205.2K | 1.2M | 3.3M | 2.7M | 3.0M | 1.6M | |
| Other Operating Expenses | 1.7M | 6.9M | 10.9M | 10.4M | 17.6M | 18.5M | |
| Operating Income | (1.7M) | (6.9M) | (10.3M) | (10.6M) | (17.3M) | (16.4M) | |
| Ebit | (1.7M) | (6.9M) | (10.3M) | (10.6M) | (17.3M) | (16.4M) | |
| Research Development | 194.3K | 4.7M | 5.3M | 5.0M | 10.6M | 11.1M | |
| Ebitda | (1.6M) | (6.8M) | (10.0M) | (10.2M) | (16.9M) | (16.0M) | |
| Total Operating Expenses | 1.7M | 6.9M | 10.4M | 10.4M | 17.6M | 18.5M | |
| Income Before Tax | (1.8M) | (9.1M) | (11.8M) | (13.7M) | (13.7M) | (13.1M) | |
| Total Other Income Expense Net | (119.6K) | (2.2M) | (1.5M) | (3.1M) | 3.5M | 3.7M | |
| Net Income | (1.8M) | (9.1M) | (11.8M) | (13.7M) | (13.7M) | (13.1M) | |
| Income Tax Expense | 4.9K | 54.3K | 21.7K | 3.3M | (5.0) | (4.75) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.012 | Return On Assets (0.61) | Return On Equity (1.22) |
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.